Sign in
8-K

Current Report

Calidi Biotherapeutics, Inc. Filed Acc 0001193125-23-100724

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d438294d8k.htm…